Benchmark Downgrades Omnicell (OMCL) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Benchmark Downgrades Omnicell (OMCL) to Hold

Omnicell Announces Financial Results for Third Quarter 2022

November 2, 2022 8:01 AM EDT

GAAP and non-GAAP revenues of $348 million

GAAP net income per diluted share of $0.37

Non-GAAP net income per diluted share of $1.00

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Omnicell, Inc. (NASDAQ: OMCL) (Omnicell, we, our, us, management, or the Company), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its third quarter ended September 30, 2022 and updated 2022 guidance.

Randall Lipps, Chairman, President, Chief Executive Officer, and Founder of Omnicell, said, In the third quarter, we... More